Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP308189.RAD3ZDXOVsaxIe98TTM-SvF4HGwPiz138UF0f1tKI2w_I130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP308189.RAD3ZDXOVsaxIe98TTM-SvF4HGwPiz138UF0f1tKI2w_I130_assertion type Assertion NP308189.RAD3ZDXOVsaxIe98TTM-SvF4HGwPiz138UF0f1tKI2w_I130_head.
- NP308189.RAD3ZDXOVsaxIe98TTM-SvF4HGwPiz138UF0f1tKI2w_I130_assertion wasGeneratedBy ECO_0000203 NP308189.RAD3ZDXOVsaxIe98TTM-SvF4HGwPiz138UF0f1tKI2w_I130_provenance.
- NP308189.RAD3ZDXOVsaxIe98TTM-SvF4HGwPiz138UF0f1tKI2w_I130_assertion wasDerivedFrom befree-20140225 NP308189.RAD3ZDXOVsaxIe98TTM-SvF4HGwPiz138UF0f1tKI2w_I130_provenance.
- NP308189.RAD3ZDXOVsaxIe98TTM-SvF4HGwPiz138UF0f1tKI2w_I130_assertion SIO_000772 15313402 NP308189.RAD3ZDXOVsaxIe98TTM-SvF4HGwPiz138UF0f1tKI2w_I130_provenance.
- NP308189.RAD3ZDXOVsaxIe98TTM-SvF4HGwPiz138UF0f1tKI2w_I130_assertion evidence source_evidence_literature NP308189.RAD3ZDXOVsaxIe98TTM-SvF4HGwPiz138UF0f1tKI2w_I130_provenance.
- NP308189.RAD3ZDXOVsaxIe98TTM-SvF4HGwPiz138UF0f1tKI2w_I130_assertion description "[Although YC-1 was originally developed as a potential therapeutic agent for thrombosis and hypertension, recent studies demonstrated that YC-1 suppressed HIF-1 activity and vascular endothelial growth factor expression in cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP308189.RAD3ZDXOVsaxIe98TTM-SvF4HGwPiz138UF0f1tKI2w_I130_provenance.